Related Experiment Video
Updated: Mar 16, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
6.9K
Post chemotherapy retroperitoneal lymph node dissection in germ cell tumor: robotic way
Girdhar S Bora1, Pankaj Panwar1, Ravimohan S Mavuduru2
1Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Journal of Robotic Surgery
|August 10, 2016
Summary
Robotic surgery assists in removing challenging post-chemotherapy residual masses, reducing surgeon difficulty and patient discomfort. This evolving technology offers a new dimension in managing complex surgical cases.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Post-chemotherapy residual masses present significant surgical challenges.
- Laparoscopic removal of these masses requires extensive surgeon expertise.
- Robotic technology is emerging as a tool to aid in complex oncologic resections.
Observation:
- Robotic assistance was employed for the management of post-chemotherapy residual masses.
- The study details the experience and techniques used in these robotic-assisted procedures.
- Tips and tricks for performing such challenging surgeries were documented.
Findings:
- Robotic technology facilitates the management of difficult post-chemotherapy residual masses.
- It potentially reduces the technical difficulty and patient discomfort associated with these resections.
- The application of robotic assistance in this context is still under development.
Implications:
- Robotic assistance may expand surgical options for patients with challenging residual masses.
- Further research and experience are needed to fully establish the role of robotics in this field.
- This approach could lead to improved outcomes in complex oncologic surgery.
